TY  - GEN
AU  - Neumann,A U
AU  - Tubiana,R
AU  - Calvez,V
AU  - Robert,C
AU  - Li,T S
AU  - Agut,H
AU  - Autran,B
AU  - Katlama,C
TI  - HIV-1 rebound during interruption of highly active antiretroviral therapy has no deleterious effect on reinitiated treatment. Comet Study Group
SN  - 0269-9370
PY  - 1999///0921
KW  - Anti-HIV Agents
KW  - administration & dosage
KW  - CD4 Lymphocyte Count
KW  - Drug Administration Schedule
KW  - Drug Therapy, Combination
KW  - HIV Infections
KW  - drug therapy
KW  - HIV Protease Inhibitors
KW  - therapeutic use
KW  - HIV-1
KW  - physiology
KW  - Humans
KW  - Indinavir
KW  - Lamivudine
KW  - Male
KW  - Prospective Studies
KW  - RNA, Viral
KW  - blood
KW  - Reverse Transcriptase Inhibitors
KW  - Zidovudine
N1  - Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1097/00002030-199904160-00008
ER  -